Cannabis Law Report
JUNE 16, 2021
Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. . This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. ABOUT SANTÉ CANNABIS.
Cannabis Life Network
DECEMBER 16, 2022
Health Canada continues to drag its feet on magic mushroom therapy. ” “Currently, the best way for patients to access psilocybin is through participation in a clinical trial,” the statement said. .” They’ve granted a few Canadians this right, but others have been waiting over 400 days for a reply.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 21, 2021
The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinical trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
Cannabis Law Report
SEPTEMBER 2, 2022
The clinical trial involving the use of Filament’s psilocybin received approval from Health Canada and was conducted as part of ATMA Journey Centre’s psychedelic-assisted therapist training program. was the first Canadian private company to engage in legally authorized psilocybin-assisted therapy.
Cannabis Law Report
MAY 19, 2022
This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.
Canna Law Blog
NOVEMBER 27, 2021
is expanding rapidly as numerous neuropharmaceutical companies look to be among the first-to-market potentially revolutionary therapies. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. The post DMT Therapy: Coming to a Clinic Near You?
Veriheal
JULY 18, 2023
The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE).
Expert insights. Personalized for you.
104 
Let's personalize your content